8-KFiling Date: Oct 15, 2026
AbbVie 8-K: Executive Change (Oct 15, 2026)
Executive Change
View SEC Filing
ACC: 0001104659-26-116227
Event Type
Executive Change
Filing overview
AbbVie filed a Form 8-K (Material Event (8-K)) with the SEC on 2026-10-15. Reported items: Item 5.02 Executive Change.